Our Products
——
Landing Med AI+Cloud diagnostic technologies are used by more than 1,300 hospitals across the world. Automation, intelligence, and standardization combine to make  Landing Med’s products unique in its suitability for use in cancer screening programs for populations that lack qualified cytopathologists.

Automated Scanning
The system divides each slide into 1,080 fields of view and scans the entire slide within minutes. Two images of every field of view are recorded. One is for automated analysis by the system and the other is for optional, manual inspection of morphology by a cytopathologist.
Standardized Results
Because diagnoses are automated, they are objective and free from human error which is a major factor in the high rates of misdiagnoses associated with traditional cytology methods. Even with other automated systems on the market today, potentially cancerous cells are only highlighted; the final diagnosis is still made by a cytopathologist. Landing Qomo’s system facilitates such manual review but does not rely on it. As a result, it is highly standardized and introduces an unprecedented level of quality control to the field of cytodiagnostics.

Dual Diagnoses
Whenever a cytopathologist wishes to review the system’s diagnosis, he or she can do so by either analyzing the morphological image of any field of view or viewing the slide directly under the microscope. The system has an automated repositioning feature that will accurately locate any areas of interest on the slide. This combination of automated and expert diagnoses achieves unparalleled accuracy.

Address:B7 Medical Device Park, 818 Gaoxin Road East Lake High-Tech Zone, Wuhan, Hubei Province, China
Contact Us: Inquiry@landing-med.com